Articles On Micro-X (ASX:MX1)

The ASX had a positive day today gaining 0.8 per cent and all sectors finished in the green except resources and energy. Resources and Energy stocks fell 0.24 per cent and 0.55 per cent but the broader ASX 200 rose 0.87 per cent and all oth...

2021 is set to be another big year for ASX capital raisings with solid volumes so far in 2021. In the first nine weeks of the new year, ASX companies have raised over $1.96 billion. Although this is lower than the $3 billion raised in the f...

Source: OSABEE ,Shutterstock Summary Micro-X received MRFF funding for lightweight brain CT scanner testing via MRFF funding. The Company is confident that the brain CT product would be the fourth pillar of its commercialisation strat...

Micro-X (ASX:MX1) shares have hit a more than three-year high after the Brisbane-based portable imaging company announced it was in ... Read More The post Micro-X gains after portable X-ray company wins $8m stroke grant appeared first on St...

Micro-X has received funding commitments of $30.5 million to help expand its US footprint and fast-track new lightweight x-ray products. The publicly-listed company announced to the Australian Securities Exchange (ASX: MX1) this morning it...

On Stockhead today, Which ASX small cap IPOs were the best gainers in 2020? and, Which US stocks stand to benefit from a Joe Biden presidency? But first…   The day ahead After finishing Thursday with their worst trading performance since Ch...

ASX-listed x-ray products maker Micro-X has landed in front of small cap fund managers, seeking a cash injection to build out its United States operations.

Healthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financial for 24 years, explains ... Read More The post ScoPo’s powerplays: Bullish on mobile X-ray company Micro-X appeared first on Stockhead.

Healthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financial for 24 years, explains ... Read More The post ScoPo’s powerplays: Bullish on mobile X-ray company Micro-X appeared first on Stockhead.

For smug non-Croweaters who claim the closest Adelaide has got to technical innovation is a pie floater: shame on you. ... Read More The post Dr Boreham’s Crucible: Do these mobile X-ray deals prime Micro-X to explode? appeared first on Sto...

It’s been another positive day on the ASX in the wake of Democrats gaining control of the US Senate – but small caps have once again underperformed their larger peers. The Small Ordinaries index of 200 small-cap companies closed Friday up 1...

08 Jan 2021 - X-ray tech company, Micro-X (ASX:MX1) has secured a research and development tax incentive for the financial year ended 30 June 2020.

The US Government’s Department of Homeland Security has selected Micro-X (ASX: MX1) to develop the its new concept for airport passenger self-screening. Micro-X was chosen after a competitive process that involved submitting a white paper....

The Quickstep Holdings Limited (ASX: QHL) share price is shooting higher today following the release of its first quarter results. In late-morning trade, shares in the aerospace manufacturer are up 4% to 7.8 cents after earlier reaching as...

Healthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financial for 24 years, explains what the movers and shakers have been doing in health and gives his ASX powerplays. Themes of the week We’re coming...

Welcome to the FNArena Corporate Results Monitor. Today's Reports: ((ALG)) - Ardent Leisure ((AMS)) - Atomos ((AFG)) - Australian Finance ((ASG)) - Autosports Group ((BLD)) - Boral ((CWP)) - Cedar Woods Properties ((CGC)) - Costa Group ((...

Healthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financial for 24 years, explains what the movers and shakers have been doing in health and gives his ASX powerplays.   Themes of the week Earnings s...

The COVID-19 pandemic left a lot of medical device companies scrambling to keep up with the unprecedented disruption. And when we caught up with Micro-X (ASX:MX1) CEO Peter Rowland earlier this week, he said the main challenge was presented...

Healthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financial for 24 years, explains what the movers and shakers have been doing in health and gives his ASX powerplays.   Themes of the week Scott Powe...

New research indicates Imagion Biosystems’ (ASX: IBX)  imaging particles could bring down Tesla — in MRIs that is, not the car brand. A University of Sydney study shows Imagion’s iron oxide nanoparticles enable low-field magnetic resonance...

Australian x-ray products manufacturer Micro-X Ltd [ASX:MX1] has had its share price open higher today thanks to record time FDA approval for its ‘Rover’ device. MX1 designs and develops lightweight x-ray products for global healthcare and...

Australian technology company Micro-X (ASX: MX1) has obtained early approval from the United States Food and Drug Administration (FDA) to sell its Rover mobile medical x-ray device in the US. The company lodged its 510(k) submission for the...

Portable x-ray manufacturer Micro-X (ASX:MX1) has announced its Rover product has been given FDA 510(k) clearance in just five weeks. Rover is intended for defence forces that build temporary medical facilities and require portable equipmen...

Stockhead’s Top 10 at 10 highlights the best (and worst) performing ASX small caps in morning trade. It’s a short, sharp update to help frame the trading day by showing the biggest movers in percentage terms. The market opens at 10am (easte...

Healthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financial for 24 years, explains what the movers and shakers have been doing in health and gives his ASX powerplays.   Themes of the week The market...

Healthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financial for 24 years, explains what the movers and shakers have been doing in health and gives his ASX powerplays.   Themes of the week The life s...

Bell Financial Group (ASX:BFG) is expecting to book a higher $23.5m first-half profit, but investors didn’t seem overly happy about it with shares dipping 5.2 per cent on Friday morning. The figure is 5 per cent up on the same period last y...

Healthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financial for 24 years, explains what the movers and shakers have been doing in health and gives his ASX powerplays.   Themes of the week Victoria h...

Since restrictions on elective surgery were lifted, some stocks in the elective surgery space have seen windfalls that may cancel out the COVID-19 losses. In late March, the Morrison government imposed restrictions on elective surgery to fr...

The past fortnight has seen another interesting list of buyers and sellers. Angel Seafood (ASX:AS1) CEO Issac Lee Halman had to sell $195,000 in shares to pay a tax bill. The company said he had no other choice because the majority of his a...

Healthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financial for 24 years, explains what the movers and shakers have been doing in health and gives his ASX powerplays.   Themes of the week Now invest...

Want to know which stocks the fund managers have been putting their money in (and out) of? We’ve been keeping track so you don’t have to. Trading Places is Stockhead’s recap of substantial holder movements among ASX small caps in the last f...

Participating in small cap raises is proving lucrative for investors, with shares in 47 small caps that tapped equity markets in April currently trading higher than the price at which they raised cash. Stockhead counted at least 66 offers i...

Healthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financial for 24 years, explains what the movers and shakers have been doing in health and gives his ASX powerplays.   Themes of the week Cochlear’s...

Pre-revenue biotech and medtech companies are still not eligible for the Jobkeeper wage subsidy according to the ATO, a double whammy for a swathe of research-driven ASX businesses with large staff costs. The Jobkeeper program allows busine...

Want to know which stocks the fund managers have been putting their money in (and out) of? We’ve keen keeping track so you don’t have to. Trading Places is Stockhead’s recap of substantial holder movements among ASX small caps in the last f...

It’s still a relatively difficult market to raise capital in, particularly at the junior end, but there are some that have convinced investors to part with their hard earned cash. We run through just which small and micro caps successfully...

Healthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financial for 24 years, explains what the movers and shakers have been doing in health and gives his ASX powerplays.   This week’s three big themes...

Morgans Senior Analyst Scott Power updates the network with information on 3 companies: Volpara (ASX:VHT), Impedimed (ASX:IPD) and Micro-X (ASX:MX1).

Listed X-ray technology company Micro-X Ltd was in the market on Wednesday, seeking $15 million of new equity.

Micro-X Ltd (ASX: MX1), an Australian hi-tech company, on 7 April 2020, announced to have received purchase orders valued at $1.2 million for the Carestream DRX Revolution Nano, majorly for Australian customers. Of the total, MX1 secured pu...

X-ray technology company Micro-X (ASX: MX1) has posted stronger-than-expected first quarter results as orders for its mobile x-ray system grow “substantially” in response to coronavirus-stimulated demand. The company said the rapidly growin...

Stockhead’s Top 10 at 10 highlights the best (and worst) performing ASX small caps in morning trade. It’s a short, sharp update to help frame the trading day by showing the biggest movers in percentage terms. The market opens at 10am (easte...

Coronavirus continues to drive sales into Asia and Europe for South Australian hi-tech x-ray manufacturer Micro-X. The Adelaide-based company reported to the ASX last week that sales of its flagship lightweight mobile x-ray machine had reac...

As with the early medical cannabis plays, a cluster of ASX-listed stocks has wasted little time attaching itself to the ‘c’ word. We’re talking of course about the coronavirus COVID-19 but sadly not another ‘c’ word: cure. Or not yet. Accor...

Micro-X (ASX: MX1) has collared an additional $1 million in sales for its mobile x-ray technology as governments worldwide scramble to get on top of the coronavirus COVID-19 outbreak. The additional $1 million order follows purchase orders...

Neuroscience tech company Cogstate (ASX:CGS) produced some much needed good news today, saying it has executed $9.1m of clinical trials sales contracts since the start of 2020. The stock — up about 30 per cent on the news — says this revenu...

You don’t need a PhD to run a biotech, but sometimes it helps, as these companies deal in one of the most complicated mysteries still to be solved today: the human body. Biotech CEOs and chairs tend to be the cross-over scientists. However,...

Did you know that a hard-working stallion ejaculates 100 times more sperm than the average bloke? Given a virile, but weary, thoroughbred can service hundreds of mares in a breeding season, that’s just as well. But even the most virile of t...

Stockbroker Morgans is expected to close the books on an equity raising for lightweight X-ray products maker Micro-X.